Cam Gallagher, President and CEO, and Pamela Munster, MD, Founder and Chief Scientific Advisor, will present a company ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a ...

KYZATREX ® is a controlled substance (CIII) because it contains testosterone. It is not known if KYZATREX ® is safe or effective in males younger than 18 years old. Improper use may affect bone growth ...

Cryotherapy Market OverviewThe Cryotherapy Market is projected to grow at a rate of around 7% by 2028, driven by rising incidences of sports injuries and cancer, continuous technological advancements, ...

Because the risk of many conditions increases with age, doctors generally recommend more frequent lab testing as you get ...

January 7, 2026) - Liv Hospital continues to strengthen its preventive healthcare services by offering structured full-body check-up programs designed to support early diagnosis, health risk ...

Genetics play a role in low testosterone for some men, but underlying causes vary widely. Many genes influence testosterone ...

A Comprehensive OverviewThe global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2025 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR (Compound Annual Growth ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase ...

Scan.com, a UK-based platform, offers access to private diagnostic scans, including MRI, ultrasound, and CT scans, conducted ...